These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38496976)
1. C-3 Steroidal Hemiesters as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 10. Hanzlova M; Slavikova B; Morozovova M; Musilek K; Rotterova A; Zemanová L; Kudova E ACS Omega; 2024 Mar; 9(10):12116-12124. PubMed ID: 38496976 [TBL] [Abstract][Full Text] [Related]
2. Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17β-hydroxysteroid dehydrogenase type 10. Boutin S; Roy J; Maltais R; Alata W; Calon F; Poirier D Bioorg Med Chem Lett; 2018 Dec; 28(22):3554-3559. PubMed ID: 30297283 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitors: Selectivity, metabolic stability and enhanced potency. Boutin S; Maltais R; Roy J; Poirier D Eur J Med Chem; 2021 Jan; 209():112909. PubMed ID: 33081987 [TBL] [Abstract][Full Text] [Related]
4. Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders. Yang SY; He XY; Isaacs C; Dobkin C; Miller D; Philipp M J Steroid Biochem Mol Biol; 2014 Sep; 143():460-72. PubMed ID: 25007702 [TBL] [Abstract][Full Text] [Related]
5. Development of submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluation. Benek O; Vaskova M; Miskerikova M; Schmidt M; Andrys R; Rotterova A; Skarka A; Hatlapatkova J; Karasova JZ; Medvecky M; Hroch L; Vinklarova L; Fisar Z; Hroudova J; Handl J; Capek J; Rousar T; Kobrlova T; Dolezal R; Soukup O; Aitken L; Gunn-Moore F; Musilek K Eur J Med Chem; 2023 Oct; 258():115593. PubMed ID: 37390508 [TBL] [Abstract][Full Text] [Related]
6. Physiologically relevant fluorescent assay for identification of 17β-hydroxysteroid dehydrogenase type 10 inhibitors. Schmidt M; Vaskova M; Rotterova A; Fiandova P; Miskerikova M; Zemanova L; Benek O; Musilek K J Neurochem; 2023 Oct; 167(2):154-167. PubMed ID: 37458164 [TBL] [Abstract][Full Text] [Related]
7. Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase. He XY; Yang YZ; Peehl DM; Lauderdale A; Schulz H; Yang SY J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):191-8. PubMed ID: 14672739 [TBL] [Abstract][Full Text] [Related]
8. Involvement of Type 10 17β-Hydroxysteroid Dehydrogenase in the Pathogenesis of Infantile Neurodegeneration and Alzheimer's Disease. He XY; Frackowiak J; Dobkin C; Brown WT; Yang SY Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139430 [TBL] [Abstract][Full Text] [Related]
9. Novel Benzothiazole-based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment. Aitken L; Benek O; McKelvie BE; Hughes RE; Hroch L; Schmidt M; Major LL; Vinklarova L; Kuca K; Smith TK; Musilek K; Gunn-Moore FJ Molecules; 2019 Jul; 24(15):. PubMed ID: 31362457 [No Abstract] [Full Text] [Related]
10. 6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: Design, synthesis and in vitro evaluation. Benek O; Hroch L; Aitken L; Dolezal R; Guest P; Benkova M; Soukup O; Musil K; Kuca K; Smith TK; Gunn-Moore F; Musilek K Med Chem; 2017 Jan; ():. PubMed ID: 28067167 [TBL] [Abstract][Full Text] [Related]
11. Nanomolar Benzothiazole-Based Inhibitors of 17β-HSD10 with Cellular Bioactivity. Hanzlova M; Miskerikova MS; Rotterova A; Chalupova K; Jurkova K; Hamsikova M; Andrys R; Haleckova A; Svobodova J; Schmidt M; Benek O; Musilek K ACS Med Chem Lett; 2023 Dec; 14(12):1724-1732. PubMed ID: 38116418 [TBL] [Abstract][Full Text] [Related]
12. Friend or enemy? Review of 17β-HSD10 and its role in human health or disease. Vinklarova L; Schmidt M; Benek O; Kuca K; Gunn-Moore F; Musilek K J Neurochem; 2020 Nov; 155(3):231-249. PubMed ID: 32306391 [TBL] [Abstract][Full Text] [Related]
13. Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase. He XY; Wegiel J; Yang SY Brain Res; 2005 Apr; 1040(1-2):29-35. PubMed ID: 15804423 [TBL] [Abstract][Full Text] [Related]
14. Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer's Disease Treatment. Schmidt M; Benek O; Vinklarova L; Hrabinova M; Zemanova L; Chribek M; Kralova V; Hroch L; Dolezal R; Lycka A; Prchal L; Jun D; Aitken L; Gunn-Moore F; Kuca K; Musilek K Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192199 [TBL] [Abstract][Full Text] [Related]
15. Infantile Neurodegeneration Results from Mutants of 17β-Hydroxysteroid Dehydrogenase Type 10 Rather Than Aβ-Binding Alcohol Dehydrogenase. He XY; Dobkin C; Brown WT; Yang SY Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239833 [TBL] [Abstract][Full Text] [Related]
16. Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone. Ngueta AD; Roy J; Maltais R; Poirier D Molecules; 2023 Jan; 28(2):. PubMed ID: 36677690 [TBL] [Abstract][Full Text] [Related]
17. Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone. Bellavance E; Luu-The V; Poirier D J Med Chem; 2009 Dec; 52(23):7488-502. PubMed ID: 19772289 [TBL] [Abstract][Full Text] [Related]
18. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase. Yang SY; He XY; Schulz H Trends Endocrinol Metab; 2005; 16(4):167-75. PubMed ID: 15860413 [TBL] [Abstract][Full Text] [Related]
19. Levels of 17β-hydroxysteroid dehydrogenase type 10 in CSF are not a valuable biomarker for multiple sclerosis. Kristofikova Z; Ricny J; Kaping D; Klaschka J; Kotoucova J; Bartos A Biomark Med; 2018 Dec; 12(12):1331-1340. PubMed ID: 30520659 [TBL] [Abstract][Full Text] [Related]
20. Estrone C15 derivatives--a new class of 17beta-hydroxysteroid dehydrogenase type 1 inhibitors. Messinger J; Husen B; Koskimies P; Hirvelä L; Kallio L; Saarenketo P; Thole H Mol Cell Endocrinol; 2009 Mar; 301(1-2):216-24. PubMed ID: 19014997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]